Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis
暂无分享,去创建一个
R. Markwald | S. Ghatak | S. Misra | V. Hascall | E. Maytin | J. Mack | I. Atanelishvili | Ricardo Moreno Rodríguez
[1] R. Hull,et al. Hyaluronan , 2015, Biology of Extracellular Matrix.
[2] Swati Pradhan-Bhatt,et al. Hyaluronan: a simple polysaccharide with diverse biological functions. , 2014, Acta biomaterialia.
[3] D. Vigetti,et al. Metabolic control of hyaluronan synthases. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[4] G. Hart,et al. The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[5] R. Markwald,et al. Overexpression of c-Met and CD44v6 Receptors Contributes to Autocrine TGF-β1 Signaling in Interstitial Lung Disease* , 2014, The Journal of Biological Chemistry.
[6] R. Levine,et al. Periostin Induces Intracellular Cross-talk between Kinases and Hyaluronan in Atrioventricular Valvulogenesis* , 2014, The Journal of Biological Chemistry.
[7] K. Venkateswara Swamy,et al. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells. , 2013, Bioorganic & medicinal chemistry.
[8] A. Phillips,et al. Transforming Growth Factor-β1 (TGF-β1)-stimulated Fibroblast to Myofibroblast Differentiation Is Mediated by Hyaluronan (HA)-facilitated Epidermal Growth Factor Receptor (EGFR) and CD44 Co-localization in Lipid Rafts* , 2013, The Journal of Biological Chemistry.
[9] E. Harris,et al. The Hyaluronan Receptor for Endocytosis (HARE) Activates NF-κB-mediated Gene Expression in Response to 40–400-kDa, but Not Smaller or Larger, Hyaluronans* , 2013, The Journal of Biological Chemistry.
[10] Yoshinori Sugiyama,et al. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization , 2013, Proceedings of the National Academy of Sciences.
[11] Hui Liu,et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. , 2013, The Journal of clinical investigation.
[12] Lorin E. Olson,et al. Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities , 2013, Current Rheumatology Reports.
[13] J. Warnet,et al. Hyaluronan Fragments Improve Wound Healing on In Vitro Cutaneous Model through P2X7 Purinoreceptor Basal Activation: Role of Molecular Weight , 2012, PloS one.
[14] J. Couchman,et al. An Introduction to Proteoglycans and Their Localization , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[15] M. Tammi,et al. Role of UDP-N-Acetylglucosamine (GlcNAc) and O-GlcNAcylation of Hyaluronan Synthase 2 in the Control of Chondroitin Sulfate and Hyaluronan Synthesis* , 2012, The Journal of Biological Chemistry.
[16] V. Thannickal,et al. Targeting NOX enzymes in pulmonary fibrosis , 2012, Cellular and Molecular Life Sciences.
[17] R. Markwald,et al. 8.9 Delivery systems targeting cancer at the level of ECM , 2012 .
[18] R. Markwald,et al. 8.2 Targeting the tumor microenvironment in cancer progression , 2012 .
[19] F. Marincola,et al. Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[20] P. Stattin,et al. Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome. , 2011, The American journal of pathology.
[21] V. Hascall,et al. Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 , 2011, The Journal of investigative dermatology.
[22] A. Vasanji,et al. Pericellular Versican Regulates the Fibroblast-Myofibroblast Transition , 2011, The Journal of Biological Chemistry.
[23] M. Jadot,et al. Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase. , 2011, Biochemical and biophysical research communications.
[24] E. B. Meltzer,et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44 , 2011, The Journal of experimental medicine.
[25] R. Markwald,et al. Hyaluronan–CD44 interactions as potential targets for cancer therapy , 2011, The FEBS journal.
[26] M. Tammi,et al. Transcriptional and post‐translational regulation of hyaluronan synthesis , 2011, The FEBS journal.
[27] M. Zöller. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? , 2011, Nature Reviews Cancer.
[28] A. Phillips,et al. Hyaluronan Facilitates Transforming Growth Factor-β1-dependent Proliferation via CD44 and Epidermal Growth Factor Receptor Interaction , 2011, The Journal of Biological Chemistry.
[29] M. Zöller,et al. CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance* , 2011, The Journal of Biological Chemistry.
[30] V. Hascall,et al. Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[31] A. Leask. Possible strategies for anti-fibrotic drug intervention in scleroderma , 2011, Journal of Cell Communication and Signaling.
[32] R. Vaillancourt,et al. TGFβ2-mediated production of hyaluronan is important for the induction of epicardial cell differentiation and invasion. , 2010, Experimental cell research.
[33] D. Abraham,et al. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. , 2010, The Journal of investigative dermatology.
[34] Christina K. Chan,et al. Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse , 2010, Cellular and Molecular Immunology.
[35] R. Markwald,et al. Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor* , 2010, The Journal of Biological Chemistry.
[36] E. Maytin,et al. Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice. , 2010, The Journal of investigative dermatology.
[37] S. Campo,et al. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. , 2010, Biochimie.
[38] M. Longaker,et al. Interaction of Wingless Protein (Wnt), Transforming Growth Factor-&bgr;1, and Hyaluronan Production in Fetal and Postnatal Fibroblasts , 2010, Plastic and reconstructive surgery.
[39] R. Xing,et al. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy. , 2009, Oral diseases.
[40] E. Maytin,et al. Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFR. , 2009, The Journal of investigative dermatology.
[41] Roger R Markwald,et al. Delivery of CD44 shRNA/Nanoparticles within Cancer Cells , 2009, Journal of Biological Chemistry.
[42] A. Ghahary,et al. Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts. , 2009, The Journal of investigative dermatology.
[43] P. Olczyk,et al. [Hyaluronan: structure, metabolism, functions, and role in wound healing]. , 2008, Postepy higieny i medycyny doswiadczalnej.
[44] Neha S. Gandhi,et al. The Structure of Glycosaminoglycans and their Interactions with Proteins , 2008, Chemical biology & drug design.
[45] G. Karakiulakis,et al. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension , 2008, European Respiratory Journal.
[46] J. Edwards,et al. Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.
[47] M. Trojanowska. Role of PDGF in fibrotic diseases and systemic sclerosis. , 2008, Rheumatology.
[48] E. Carmona,et al. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation. , 2008, Matrix biology : journal of the International Society for Matrix Biology.
[49] Byung-Soo Kim,et al. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation. , 2008, Journal of biomedical materials research. Part A.
[50] Ronit Vogt Sionov,et al. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. , 2008, Seminars in cancer biology.
[51] E. Harris,et al. The Cytoplasmic Domain of the Hyaluronan Receptor for Endocytosis (HARE) Contains Multiple Endocytic Motifs Targeting Coated Pit-mediated Internalization* , 2008, Journal of Biological Chemistry.
[52] Y. Hannun,et al. Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma Cells* , 2008, Journal of Biological Chemistry.
[53] A. Campos,et al. Assessment and nutritional aspects of wound healing , 2008, Current opinion in clinical nutrition and metabolic care.
[54] E. Turley,et al. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? , 2008, Journal of Cell Science.
[55] G. Prestwich,et al. Prevention of peritendinous adhesions using a hyaluronan‐derived hydrogel film following partial‐thickness flexor tendon injury , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[56] K. Törrönen,et al. All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes. , 2008, The Journal of investigative dermatology.
[57] A. Phillips,et al. Hyaluronan Facilitates Transforming Growth Factor-β1-mediated Fibroblast Proliferation* , 2008, Journal of Biological Chemistry.
[58] J. Pujol,et al. Differential effects of hyaluronan and its fragments on fibroblasts: Relation to wound healing , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[59] Glenn D Prestwich,et al. Engineering a clinically-useful matrix for cell therapy , 2008, Organogenesis.
[60] R. Markwald,et al. Hyaluronan, CD44, and Cyclooxygenase-2 in Colon Cancer , 2008, Connective tissue research.
[61] P. Noble,et al. Hyaluronan in tissue injury and repair. , 2007, Annual review of cell and developmental biology.
[62] E. Balazs,et al. Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.
[63] A. Phillips,et al. Involvement of Hyaluronan in Regulation of Fibroblast Phenotype* , 2007, Journal of Biological Chemistry.
[64] Yu-Kyoung Oh,et al. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[65] O. Herzberg,et al. Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis. , 2007, Biochemistry.
[66] David Abraham,et al. Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.
[67] M. Takahashi,et al. CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2* , 2007, Journal of Biological Chemistry.
[68] S. Ghatak,et al. Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells* , 2006, Journal of Biological Chemistry.
[69] W. Knudson,et al. Acylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis* , 2006, Journal of Biological Chemistry.
[70] Glenn D Prestwich,et al. Molecular stenting with a crosslinked hyaluronan derivative inhibits collagen gel contraction. , 2006, The Journal of investigative dermatology.
[71] Robert Stern,et al. Hyaluronan fragments: an information-rich system. , 2006, European journal of cell biology.
[72] George Broughton,et al. The Basic Science of Wound Healing , 2006, Plastic and reconstructive surgery.
[73] R. Gallo,et al. Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[74] C. A. de la Motte,et al. Hyaluronan cross-linking: a protective mechanism in inflammation? , 2005, Trends in immunology.
[75] C. Isacke,et al. Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding , 2005, Journal of Cell Science.
[76] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[77] Sabrina Cattaruzza,et al. Proteoglycan control of cell movement during wound healing and cancer spreading. , 2005, Matrix biology : journal of the International Society for Matrix Biology.
[78] V. Hascall,et al. Hoxb13 Up-regulates Transglutaminase Activity and Drives Terminal Differentiation in an Epidermal Organotypic Model* , 2005, Journal of Biological Chemistry.
[79] P. Peplow. Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds , 2005, Thrombosis and Haemostasis.
[80] T. Thatcher,et al. PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis , 2005 .
[81] S. Ghatak,et al. Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2*♦ , 2005, Journal of Biological Chemistry.
[82] C. Carlberg,et al. The Human Hyaluronan Synthase 2 Gene Is a Primary Retinoic Acid and Epidermal Growth Factor Responding Gene* , 2005, Journal of Biological Chemistry.
[83] S. Ghatak,et al. Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells* , 2005, Journal of Biological Chemistry.
[84] E. Wouters,et al. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation , 2005, Thorax.
[85] Kristen W. Lynch,et al. Consequences of regulated pre-mRNA splicing in the immune system , 2004, Nature Reviews Immunology.
[86] Shi-min Chang,et al. [Examination of serum hyaluronic acid level in patients with oral and maxillofacial malignancy]. , 2004, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology.
[87] Yihai Cao,et al. Impaired Angiogenesis, Delayed Wound Healing and Retarded Tumor Growth in Perlecan Heparan Sulfate-Deficient Mice , 2004, Cancer Research.
[88] C. A. de la Motte,et al. Intracellular hyaluronan: a new frontier for inflammation? , 2004, Biochimica et biophysica acta.
[89] T. Krieg,et al. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. , 2004, The American journal of pathology.
[90] N. Williams,et al. Identification and Analysis of the Promoter Region of the Human Hyaluronan Synthase 2 Gene* , 2004, Journal of Biological Chemistry.
[91] A. Barbul,et al. Understanding the role of immune regulation in wound healing. , 2004, American journal of surgery.
[92] R. Stern,et al. Clinical and Laboratory Investigations Aberrant serum hyaluronan and hyaluronidase levels in scleroderma , 2004 .
[93] Ankush Gosain,et al. Aging and Wound Healing , 2004, World Journal of Surgery.
[94] Brown Ja. The role of hyaluronic acid in wound healing’s proliferative phase , 2004 .
[95] K. Törrönen,et al. Keratinocyte Growth Factor Stimulates Migration and Hyaluronan Synthesis in the Epidermis by Activation of Keratinocyte Hyaluronan Synthases 2 and 3* , 2003, Journal of Biological Chemistry.
[96] Timothy A. Springer,et al. Therapeutic antagonists and conformational regulation of integrin function , 2003, Nature Reviews Drug Discovery.
[97] L. Bourguignon,et al. Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression* , 2003, Journal of Biological Chemistry.
[98] S. Ghatak,et al. Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan* , 2003, Journal of Biological Chemistry.
[99] V. Hascall,et al. Hoxb13 knockout adult skin exhibits high levels of hyaluronan and enhanced wound healing , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[100] Mikko J Lammi,et al. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. , 2003, The Journal of investigative dermatology.
[101] J. Keats,et al. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. , 2003, Molecular biology of the cell.
[102] J. Sleeman,et al. CD44 is required for two consecutive steps in HGF/c-Met signaling. , 2002, Genes & development.
[103] M. Stepp,et al. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse , 2002, Journal of Cell Science.
[104] S. Ghatak,et al. Hyaluronan Oligosaccharides Inhibit Anchorage-independent Growth of Tumor Cells by Suppressing the Phosphoinositide 3-Kinase/Akt Cell Survival Pathway* , 2002, The Journal of Biological Chemistry.
[105] K. Kimata,et al. Mammalian Hyaluronan Synthases , 2002, IUBMB life.
[106] Glenn D Prestwich,et al. Disulfide cross-linked hyaluronan hydrogels. , 2002, Biomacromolecules.
[107] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[108] R. Midura,et al. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes , 2002, Journal of Cell Science.
[109] V. Hascall,et al. Hyaluronan and tumor growth. , 2002, The American journal of pathology.
[110] S. Klewer,et al. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.
[111] E. Puré,et al. Resolution of Lung Inflammation by CD44 , 2002, Science.
[112] V. Hascall,et al. Hyaluronan Minireview Series* , 2002, The Journal of Biological Chemistry.
[113] Lilly Y. W. Bourguignon,et al. Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.
[114] S. Nedvetzki,et al. CD44 in Cancer , 2002, Critical reviews in clinical laboratory sciences.
[115] Kevin Barraclough,et al. I and i , 2001, BMJ : British Medical Journal.
[116] L. DiPietro,et al. Age-related alterations in the inflammatory response to dermal injury. , 2001, The Journal of investigative dermatology.
[117] M. Tammi,et al. Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism* , 2001, The Journal of Biological Chemistry.
[118] Johnny Huard,et al. The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration * , 2001, The American journal of sports medicine.
[119] M. Tammi,et al. Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan* , 2001, The Journal of Biological Chemistry.
[120] K. Matsumoto,et al. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. , 2001, Kidney international.
[121] C. Soranzo,et al. Extensive traumatic soft tissue loss: reconstruction in severely injured patients using cultured hyaluronan-based three-dimensional dermal and epidermal autografts. , 2001, The Journal of trauma.
[122] P. Sime,et al. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[123] T. Mak,et al. CD44-Deficient Mice Exhibit Enhanced Hepatitis After Concanavalin A Injection: Evidence for Involvement of CD44 in Activation-Induced Cell Death1 , 2001, The Journal of Immunology.
[124] E. Puré,et al. A crucial role for CD44 in inflammation. , 2001, Trends in molecular medicine.
[125] C. Haipek,et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. , 2001, Genes & development.
[126] F. Duh,et al. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[127] L. Bourguignon,et al. CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration* , 2001, The Journal of Biological Chemistry.
[128] M. Detmar,et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. , 2001, The Journal of clinical investigation.
[129] R. Cortivo,et al. In vitro reconstructed dermis implanted in human wounds: degradation studies of the HA-based supporting scaffold. , 2000, Biomaterials.
[130] A. Spicer,et al. Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.
[131] S. Klewer,et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.
[132] I. Campbell,et al. Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. , 2000, Structure.
[133] J. Albina,et al. Macrophage-Induced Neutrophil Apoptosis1 , 2000, The Journal of Immunology.
[134] E. Puré,et al. Oncostatin M and Transforming Growth Factor-β1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells* , 2000, The Journal of Biological Chemistry.
[135] S. Kohno,et al. Expression of CD44 Variants in Lung Cancer and Its Relationship to Hyaluronan Binding , 2000, The Journal of international medical research.
[136] L. Bourguignon,et al. CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration* , 2000, The Journal of Biological Chemistry.
[137] K. Prydz,et al. Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.
[138] F. Hilberg,et al. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. , 1999, Journal of immunology.
[139] T. Hardingham,et al. The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. , 1999, Biophysical journal.
[140] S. Scherer,et al. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. , 1999, Genomics.
[141] P. Lenas,et al. Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties* , 1999, The Journal of Biological Chemistry.
[142] T. Mak,et al. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. , 1999, Journal of immunology.
[143] G. Abatangelo,et al. Functions of hyaluronan in wound repair , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[144] D. Jackson,et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.
[145] A. Maiti,et al. TNF-α Induction of CD44-Mediated Leukocyte Adhesion by Sulfation , 1998 .
[146] R. Wüthrich,et al. Mechanisms of Hyaluronan-Induced Up-Regulation of ICAM-1 and VCAM-1 Expression by Murine Kidney Tubular Epithelial Cells: Hyaluronan Triggers Cell Adhesion Molecule Expression Through a Mechanism Involving Activation of Nuclear Factor-κB and Activating Protein-1 , 1998, The Journal of Immunology.
[147] J. Plouët,et al. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. , 1998, Biology of the cell.
[148] G. Kreil,et al. HYAL2, a Human Gene Expressed in Many Cells, Encodes a Lysosomal Hyaluronidase with a Novel Type of Specificity* , 1998, The Journal of Biological Chemistry.
[149] S. Kumar,et al. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[150] P. Johnson,et al. Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate. , 1998, Journal of cell science.
[151] I. Stamenkovic,et al. Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan , 1998, The Journal of cell biology.
[152] R. Stern,et al. Purification and microsequencing of hyaluronidase isozymes from human urine , 1997, FEBS letters.
[153] B. Toole,et al. Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.
[154] D. West,et al. Serum hyaluronan levels follow disease activity in vasculitis. , 1997, Clinical nephrology.
[155] D. Naor,et al. Hyaluronan‐independent lodgment of CD44+ lymphoma cells in lymphoid organs , 1997, International journal of cancer.
[156] J. Banyard,et al. Differential response of fetal and adult fibroblasts to cytokines: cell migration and hyaluronan synthesis. , 1997, Development.
[157] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[158] K. Weber,et al. Tissue repair and angiotensin II generated at sites of healing , 1997, Basic Research in Cardiology.
[159] M. Horton,et al. Hyaluronan Fragments Induce Nitric-oxide Synthase in Murine Macrophages through a Nuclear Factor κB-dependent Mechanism* , 1997, The Journal of Biological Chemistry.
[160] J. Hogg,et al. Proteoglycan deposition in pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.
[161] M. Burdick,et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. , 1996, The Journal of clinical investigation.
[162] I. Ellis,et al. Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing. , 1996, Experimental cell research.
[163] I. Campbell,et al. Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration , 1996, Cell.
[164] J. Sleeman,et al. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. , 1996, Cancer research.
[165] E. Turley,et al. HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.
[166] K. Burridge,et al. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions , 1996, The Journal of cell biology.
[167] Y. Kaneda,et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.
[168] M. Levesque,et al. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. , 1996, Journal of immunology.
[169] Mark Eastwood,et al. Quantitative analysis of collagen gel contractile forces generated by dermal fibroblasts and the relationship to cell morphology , 1996, Journal of cellular physiology.
[170] G. Kreil. Hyaluronidases — a group of neglected enzymes , 1995, Protein science : a publication of the Protein Society.
[171] W. Kenney,et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. , 1995, The Journal of clinical investigation.
[172] M. Longaker,et al. The in vivo effect of hyaluronan associated protein-collagen complex on wound repair. , 1995, Biochemistry and molecular biology international.
[173] A. Perschl,et al. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation , 1995, The Journal of experimental medicine.
[174] K. Oritani,et al. Glycosylation of CD44 negatively regulates its recognition of hyaluronan , 1995, The Journal of experimental medicine.
[175] D. Foreman,et al. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.
[176] E. Puré,et al. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain , 1995, The Journal of experimental medicine.
[177] R. D. du Bois,et al. Insulin-like growth factor-I is partially responsible for fibroblast proliferation induced by bronchoalveolar lavage fluid from patients with systemic sclerosis. , 1994, Clinical science.
[178] I. K. Cohen,et al. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. , 1993, Matrix.
[179] F M van den Berg,et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. , 1993, Cancer research.
[180] W. Knudson,et al. Hyaluronan‐binding proteins in development, tissue homeostasis, and disease , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[181] M. Anscher,et al. Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer , 1993 .
[182] P. Herrlich,et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.
[183] J. Bell,et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[184] Kahaleh Mb. Nerve root pain secondary to posterior articular cysts: a report of 6 cases and review of the literature. , 1992 .
[185] E. Turley,et al. Hyaluronan and cell locomotion , 1992, Cancer and Metastasis Reviews.
[186] M. Laato,et al. Induced expression of syndecan in healing wounds , 1991, The Journal of cell biology.
[187] G. Prestwich,et al. Chemical modification of hyaluronic acid by carbodiimides. , 1991, Bioconjugate chemistry.
[188] M. Ferguson,et al. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. , 1991, Development.
[189] B. Delpech,et al. Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis , 1991, The British journal of dermatology.
[190] M. Longaker,et al. Studies in Fetal Wound Healing V. A Prolonged Presence of Hyaluronic Acid Characterizes Fetal Wound Fluid , 1991, Annals of surgery.
[191] E. Turley,et al. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells , 1991, The Journal of cell biology.
[192] M. Longaker. Studies in fetal wound healing: II , 1991 .
[193] A. Abbas,et al. Cellular and Molecular Immunology , 1991 .
[194] G. Laurent,et al. The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. , 1991, Biochimica et biophysica acta.
[195] B. Asselain,et al. Serum hyaluronan (hyaluronic acid) in breast cancer patients , 1990, International journal of cancer.
[196] R. Derynck,et al. Transforming growth factor‐α , 1990, Molecular reproduction and development.
[197] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[198] F. Barry. Proteoglycans: structure and function. , 1990, Biochemical Society transactions.
[199] M. Sporn,et al. Transforming growth factor-beta: multifunctional regulator of differentiation and development. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[200] R. Hällgren,et al. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. , 1989, The American review of respiratory disease.
[201] R. Spendlove,et al. Studies in fetal wound healing: I. A factor in fetal serum that stimulates deposition of hyaluronic acid. , 1989, Journal of pediatric surgery.
[202] L. Nanney,et al. Enhancement of wound healing by topical treatment with epidermal growth factor. , 1989, The New England journal of medicine.
[203] Thomas A. Mustoe, MD, FACS,et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms , 1989, The Journal of cell biology.
[204] C. Heldin,et al. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. , 1989, The Biochemical journal.
[205] Edward Y Lee,et al. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[206] P. Pilch,et al. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. , 1989, Endocrinology.
[207] R. Crystal,et al. Alveolar macrophages release an insulin-like growth factor I-type molecule. , 1988, The Journal of clinical investigation.
[208] T. Springer,et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells , 1988, Nature.
[209] R. Colvin,et al. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[210] E. Vuorio,et al. Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. , 1987, The Biochemical journal.
[211] R. Derynck,et al. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.
[212] S. Hellström,et al. Hyaluronic acid reduces connective tissue formation in middle ears filled with absorbable gelatin sponge: an experimental study. , 1986, American journal of otolaryngology.
[213] W. H. Betts,et al. Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. , 1985, Annals of the rheumatic diseases.
[214] I. Hampson,et al. Angiogenesis induced by degradation products of hyaluronic acid. , 1985, Science.
[215] G. Abatangelo,et al. Healing of hyaluronic acid-enriched wounds: histological observations. , 1983, The Journal of surgical research.
[216] M J Bissell,et al. How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.
[217] R. Clark,et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. , 1982, The Journal of investigative dermatology.
[218] L. Culp,et al. Glycosaminoglycans that bind cold-insoluble globulin in cell-substratum adhesion sites of murine fibroblasts. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[219] B. Bhaumick,et al. Release of somatomedin-like activity by cultured WI-38 human fibroblasts. , 1980, Endocrinology.
[220] E Bell,et al. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[221] H. Green,et al. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.
[222] R. Stephenson. A and V , 1962, The British journal of ophthalmology.
[223] Hugh Gordon,et al. Scleroderma , 1937 .
[224] Karl Meyer,et al. THE POLYSACCHARIDE OF THE VITREOUS HUMOR , 1934 .
[225] W. Marsden. I and J , 2012 .
[226] P. Heldin. Growth factor regulation of hyaluronan metabolism in tumor progression , 2009 .
[227] Oliver Distler,et al. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. , 2009, Arthritis and rheumatism.
[228] Glenn D Prestwich,et al. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. , 2008, Accounts of chemical research.
[229] Oliver Distler,et al. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. , 2007, Arthritis and rheumatism.
[230] R. Savani,et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. , 2007, Matrix biology : journal of the International Society for Matrix Biology.
[231] Tarynn M Witten,et al. Impaired wound healing. , 2007, Clinics in dermatology.
[232] S. Ghatak,et al. REGULATION OF MDR 1 EXPRESSION AND DRUG RESISTANCE BY A POSITIVE FEEDBACK LOOP INVOLVING HYALURONAN , PHOSPHOINOSITIDE 3-KINASE AND ERBB 2 * , 2005 .
[233] J. Brown. The role of hyaluronic acid in wound healing's proliferative phase. , 2004, Journal of wound care.
[234] A. Cantin,et al. Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep , 2004, Lung.
[235] T. S. Wilkinson,et al. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. , 2004, American journal of respiratory cell and molecular biology.
[236] P. Herrlich,et al. CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.
[237] P. Noble. Hyaluronan and its catabolic products in tissue injury and repair. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[238] V. Hascall,et al. POLY I:C INDUCES MONONUCLEAR LEUKOCYTE-ADHESIVE HYALURONAN STRUCTURES ON COLON SMOOTH MUSCLE CELLS: IαI AND VERSICAN FACILITATE ADHESION , 2002 .
[239] V. Assmann,et al. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. , 2001, The Journal of investigative dermatology.
[240] T. Ishida. Immunohistochemical Expression of the CD44 Variant 6 in Colorectal Adenocarcinoma , 2000, Surgery Today.
[241] G. Offerhaus,et al. CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value , 1999 .
[242] A. Reiner,et al. CD44 expression in benign and malignant colorectal polyps , 1999, Diseases of the colon and rectum.
[243] I. Stamenkovic,et al. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.
[244] R. Clark,et al. Overview and General Considerations of Wound Repair , 1998 .
[245] P. Johnson,et al. TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. , 1998, Science.
[246] M. Mohamadzadeh,et al. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. , 1998, The Journal of clinical investigation.
[247] C. van Krimpen,et al. CD44 splice variants as prognostic markers in colorectal cancer. , 1998, Scandinavian journal of gastroenterology.
[248] J. Iredale. Tissue inhibitors of metalloproteinases in liver fibrosis. , 1997, The international journal of biochemistry & cell biology.
[249] M. Longaker,et al. Fibrotic healing of adult and late gestation fetal wounds correlates with increased hyaluronidase activity and removal of hyaluronan. , 1997, The international journal of biochemistry & cell biology.
[250] G. Laurent,et al. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene? , 1997, The international journal of biochemistry & cell biology.
[251] T. Franklin. Therapeutic approaches to organ fibrosis. , 1997, The international journal of biochemistry & cell biology.
[252] K. Weber,et al. Myofibroblasts and local angiotensin II in rat cardiac tissue repair. , 1997, The international journal of biochemistry & cell biology.
[253] S. Kamata,et al. Hyaluronic acid of wound fluid in adult and fetal rabbits. , 1997, Journal of pediatric surgery.
[254] M Tammi,et al. Hyaluronan synthases. , 1997, The Journal of biological chemistry.
[255] A. E. El Nahas,et al. Renal fibrosis: insights into pathogenesis and treatment. , 1997, The international journal of biochemistry & cell biology.
[256] Ronit Vogt Sionov,et al. CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.
[257] K. Burridge,et al. Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.
[258] I. Emerit,et al. Hyaluronic acid in progressive systemic sclerosis. , 1996, Dermatology.
[259] R L Bartel,et al. Characterization, barrier function, and drug metabolism of an in vitro skin model. , 1993, The Journal of investigative dermatology.
[260] M. Anscher,et al. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. , 1993, The New England journal of medicine.
[261] M. Nakamura,et al. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan. , 1992, Current eye research.
[262] M. Kahaleh. The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy). , 1992, Clinical and Experimental Rheumatology.
[263] W. Hickerson,et al. Beneficial actions of exogenous hyaluronic acid on wound healing. , 1991, Surgery.
[264] M. Longaker,et al. Hyaluronan and wound healing: a new perspective. , 1991, British journal of plastic surgery.
[265] M. Marazzi,et al. Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats. , 1990, International journal of tissue reactions.
[266] M. Sporn,et al. Transforming growth factor-beta. Major role in regulation of extracellular matrix. , 1990, Annals of the New York Academy of Sciences.
[267] M. Sporn,et al. Transforming Growth Factor , 1990 .
[268] S. Kumar,et al. Hyaluronan and angiogenesis. , 1989, Ciba Foundation symposium.
[269] J. Folkman,et al. Angiogenic factors. , 1987, Science.
[270] J. Garland. The New England Journal of Medicine. , 1961, Canadian Medical Association journal.
[271] F. Segal,et al. A CHARACTERIZATION OF FIBRANT SEGAL CATEGORIES , 2006, math/0603400.